Literature DB >> 26637926

Prognostic Value of FDG-PET/CT Total Lesion Glycolysis for Patients with Resectable Distal Bile Duct Adenocarcinoma.

Eun Jeong Lee1, Seong-Hwan Chang2, Tae Yoon Lee3, So Young Yoon4, Young Koog Cheon3, Chan Sup Shim3, Young So5, Hyun Woo Chung6.   

Abstract

AIM: We investigated the prognostic value of clinicopathological factors in patients with a distal bile duct adenocarcinoma after curative resection. PATIENTS AND METHODS: This retrospective study included 25 patients who underwent (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG-PET/CT) before surgery. The maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured using FDG-PET/CT. FDG-PET/CT parameters and other clinicopathological factors were assessed to evaluate survival.
RESULTS: Univariate survival analysis showed that high TLG, high MTV, and high SUVmax were significant prognostic predictors for poor overall survival. For progression-free survival, high TLG and large tumor size were significant predictors for a poor prognosis. After multivariate survival analysis, only high TLG was an independent prognostic predictor for poor overall survival (p=0.025).
CONCLUSION: Preoperative assessment of TLG by FDG-PET/CT might be a useful prognostic predictor in patients with a distal bile duct adenocarcinoma after curative resection. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  cholangiocarcinoma; distal bile duct; positron-emission tomography; prognosis; total lesion glycolysis

Mesh:

Substances:

Year:  2015        PMID: 26637926

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

Review 1.  Imaging of Cholangiocarcinoma.

Authors:  Susann-Cathrin Olthof; Ahmed Othman; Stephan Clasen; Christina Schraml; Konstantin Nikolaou; Malte Bongers
Journal:  Visc Med       Date:  2016-12-06

2.  Outcomes After Radio(chemo)therapy for Non-Metastatic Bile Duct Cancer.

Authors:  Louisa Bolm; Lukas Kaesmann; Tobias Bartscht; Steven E Schild; Dirk Rades
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

3.  Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.

Authors:  Ka Wing Ma; Tan To Cheung; Wong Hoi She; Kenneth Siu Ho Chok; Albert Chi Yan Chan; Wing Chiu Dai; Wan Hang Chiu; Chung Mau Lo
Journal:  World J Surg       Date:  2018-03       Impact factor: 3.352

4.  Inverse Prognostic Relationships of 18F-FDG PET/CT Metabolic Parameters in Patients with Distal Bile Duct Cancer Undergoing Curative Surgery.

Authors:  Hyun Kyung Yi; Yong-Jin Park; Ji Hoon Bae; Jong Kyun Lee; Kwang Hyuk Lee; Seong Ho Choi; Kyung-Han Lee; Byung-Tae Kim; Joon Young Choi
Journal:  Nucl Med Mol Imaging       Date:  2018-08-30

5.  FDG PET/CT to Predict Recurrence of Early Breast Invasive Ductal Carcinoma.

Authors:  Joon-Hyung Jo; Hyun Woo Chung; Young So; Young Bum Yoo; Kyoung Sik Park; Sang Eun Nam; Eun Jeong Lee; Woo Chul Noh
Journal:  Diagnostics (Basel)       Date:  2022-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.